Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1357 of 5804
-
New hope for Hard-to-Treat cancers: experimental drug targets KRAS mutation
Disease control Recruiting nowThis study is a multicentre, open phase I clinical study of dose escalation, dose extension and efficacy extension of HRS-7058 in subjects with advanced malignant tumour. To evaluate the safety, tolerability, pharmacokinetics and efficacy of HRS-7058.
Phase: PHASE1 • Sponsor: Shandong Suncadia Medicine Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
Radiation beads plus immunotherapy: a new hope for inoperable bile duct cancer?
Disease control Recruiting nowThis phase I trial tests the safety and side effects of yttrium-90 (Y90) radioembolization combined with immunotherapy drugs tremelimumab and durvalumab in treating patients with intrahepatic cholangiocarcinoma (cancer of the bile ducts in the liver) that has spread to nearby tis…
Phase: PHASE1 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
New drug aimed at regrowing hair in severe alopecia
Disease control TerminatedThis is a parallel, Phase 2 multinational, multicenter, randomized, double-blind, placebo-controlled, 3-arm study to investigate the efficacy and safety of subcutaneous (SC) injections of amlitelimab treatment as monotherapy in participants aged 18 years and older with severe alo…
Phase: PHASE2 • Sponsor: Sanofi • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
New study tests belimumab to tame early lupus
Disease control Recruiting nowThis is a prospective, open-label, single arm 3-year clinical study to describe the short-term and long-term efficacy and safety of belimumab in participants with autoantibody positive early SLE with ongoing disease activity despite stable first-line SLE therapy.
Phase: PHASE4 • Sponsor: GlaxoSmithKline • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
Nose cells could fix your knee: new implant trial launches
Disease control Recruiting nowThe purpose of this investigator-initiated study is to assess the efficacy of treating patellofemoral osteoarthritis with an Advanced Therapy Medicinal Product (ATMP), autologous nasal chondrocyte tissue engineered cartilage (N-TEC), in comparison with a standard therapy using pl…
Phase: PHASE2 • Sponsor: University Hospital, Basel, Switzerland • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
Free fruits and veggies: a prescription for better health?
Disease control OngoingMississippi is a place deeply rooted in cultural values, yet also a place where generations of communities have experienced persistent health challenges intertwined with poverty. This project focuses on Bolivar, Washington, and Sunflower, contiguous counties in the Delta that are…
Phase: NA • Sponsor: Tufts University • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
Could stem cell exosomes help stroke patients recover?
Disease control Recruiting nowThis is a multicenter, randomized, double-blinded, placebo-controlled, dose-escalation trial. The objective of this study is evaluating safety and preliminary efficacy of intravenous exosomes derived from human induced pluripotent stem cell (GD-iExo-003) in acute ischemic stroke.
Phase: PHASE1, PHASE2 • Sponsor: Xuanwu Hospital, Beijing • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
Gene therapy trial aims to fix enzyme defect in fabry disease
Disease control Recruiting nowThe main goals of this clinical study are to characterize safety and PK/PD of AMT-191 i.e. if drug doses used in the study are safe and tolerable and to understand how it acts in the body of people with Fabry disease.
Phase: PHASE1, PHASE2 • Sponsor: UniQure Biopharma B.V. • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
Can a supercharged diet and meds beat obesity? new trial aims to find out
Disease control OngoingIn this trial, the aim is to assess the clinical benefits and harms, as well as cost-effectiveness of an intensive weight loss (IWL) intervention that includes total dietary replacements, behavioural support and weight-loss medication compared with existing weight management prog…
Phase: NA • Sponsor: Carsten Dirksen • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
New drug YL205 aims to shrink advanced tumors in early trial
Disease control Recruiting nowThis study is a multicenter, open-label, phase I/II study of YL205 in China to evaluate the safety, tolerability, PK characteristics and preliminary efficacy of YL205 in the following selected patients with advanced solid tumors.
Phase: PHASE1, PHASE2 • Sponsor: MediLink Therapeutics (Suzhou) Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
New therapy aims to ease long COVID symptoms
Symptom relief OngoingThis randomised controlled trial aims to investigate the efficacy of a psychological intervention for long COVID (LC) / post-COVID-19 syndrome (PCS) called Balance Acceptance and Commitment Therapy (Balance ACT). The primary objective of this trial is to investigate whether Bala…
Phase: NA • Sponsor: King's College London • Aim: Symptom relief
Last updated Jul 04, 2026 00:00 UTC
-
New hope for tough leukemias: revumenib trial opens
Disease control Recruiting nowTo learn if revumenib (also known as SNDX-5613) can help to control leukemias associated with an increase in expression of HOX genes.
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
New diabetes pill takes on popular drug in Head-to-Head trial
Disease control CompletedThe goal of this clinical study is to evaluate the efficacy and safety of berberine ursodeoxycholate (HTD1801) compared to dapagliflozin in patients with type 2 diabetes inadequately controlled with metformin alone.
Phase: PHASE3 • Sponsor: HighTide Biopharma Pty Ltd • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
Could a shot of your own blood ease menopause symptoms?
Symptom relief CompletedVulvovaginal health is a key aspect of active and healthy aging for all women. Hormonal deprivation that occurs during menopause significantly affects the anatomy and function of urogenital tissues, leading to their atrophy. Vaginal creams and suppositories containing estrogens a…
Phase: PHASE1, PHASE2 • Sponsor: AndreiaAntunes • Aim: Symptom relief
Last updated Jun 27, 2026 08:07 UTC
-
New heart failure drug shows promise in Mid-Stage trial
Disease control CompletedThe main purpose of this study is to evaluate the effect of AZD5462 on cardiac function in participants with chronic heart failure (HF).
Phase: PHASE2 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
New hope for psoriasis patients who Didn't respond to leading therapies
Disease control CompletedThe purpose of this research study is to evaluate the effectiveness and safety of bimekizumab in individuals with moderate-to-severe psoriasis who have failed similar therapies. Bimekizumab improves psoriasis by suppressing a type of substance found in bodies called interleukins …
Phase: PHASE4 • Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Disease control
Last updated Jun 27, 2026 12:10 UTC
-
Can a smartphone app help young people with HIV get better?
Disease control Recruiting nowThe goal of this clinical trial is to learn if the Positive Peers mobile app intervention increases rates of viral suppression in young (13-34 y/o) persons with HIV. Does use of the Positive Peers app improve viral suppression among young minority persons with HIV? What user cha…
Phase: NA • Sponsor: MetroHealth Medical Center • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
Kenya tests smartphone tool to beat child wasting crisis
Disease control Recruiting nowChild wasting is a type of malnutrition which occurs when a child becomes too thin. This medical condition increases the risk of becoming sick or dying. A child with severe wasting needs to be seen in a medical consultation to check on health status and to receive some medicine a…
Phase: NA • Sponsor: International Food Policy Research Institute • Aim: Disease control
Last updated Jul 17, 2026 00:00 UTC
-
New pill aims to keep heart in rhythm after AFib episode
Disease control OngoingRefralon® tablets in two different doses (1 or 2 tablets per day) will be evaluated vs. placebo in patients with persistent atrial fibrillation/flutter after synus rhythm restoration in order to prevent recurrence of arrhythmia. Efficacy and safety of Refralon® tablets will be st…
Phase: PHASE2 • Sponsor: National Medical Research Center for Cardiology, Ministry of Health of Russian Federation • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
Could a nurse-led online therapy beat severe fatigue in advanced cancer?
Symptom relief Recruiting nowCancer-related fatigue is highly prevalent in patients receiving treatment for gliomas or palliative systemic treatment for cancer and is experienced as one of the most burdensome symptoms affecting patients' daily functioning and quality of life. From the KWF-sponsored TIRED tri…
Phase: NA • Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC